The anti-cancer tyrosine kinase inhibitor sorafenib reduces cardiac contractile force by reducing cardiomyocyte calcium transient amplitude
Author: | C. Schneider, M. Wallner, Martin PichlerGND, D. Von Lewinski, S. Sedej, P.P. Rainer |
---|---|
Frontdoor URL | https://opus.bibliothek.uni-augsburg.de/opus4/102823 |
ISSN: | 0195-668XOPAC |
ISSN: | 1522-9645OPAC |
Parent Title (English): | European Heart Journal |
Publisher: | Oxford University Press (OUP) |
Type: | Article |
Language: | English |
Year of first Publication: | 2017 |
Release Date: | 2023/03/17 |
Tag: | Cardiology and Cardiovascular Medicine |
Volume: | 38 |
Issue: | suppl_1 |
DOI: | https://doi.org/10.1093/eurheartj/ehx493.p5257 |
Institutes: | Medizinische Fakultät |
Medizinische Fakultät / Universitätsklinikum | |
Medizinische Fakultät / Professur für Translationale Krebsforschung |